Abstract
Patients with squamous cell carcinoma of the head and neck (SCCHN) present with a severe risk of malnutrition, which is related to tumor location, catabolic status of the disease, treatment toxicity and sociocultural background. Treatment of locally advanced SCCHN, with concurrent chemoradiotherapy (CCRT) is associated with local and systemic toxicity leading to weight loss and malnutrition. Although malnutrition is a global concern linked to morbidity, mortality and high healthcare related costs, the diagnostic criteria for this condition and their application on the clinical setting are not consensual.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
